<DOC>
	<DOCNO>NCT01729793</DOCNO>
	<brief_summary>The primary objective study assess efficacy Digestive Enzyme Blend # 2 , digestive enzyme dietary supplement product , marker indicative inflammation meal . The marker assess blood level tumor necrosis factor alpha ( TNF-alpha ) , interleukin-1 beta ( IL-1beta ) , interleukin-6 ( IL-6 ) , high sensitivity C-reactive protein ( hsCRP ) time 0 , 45 minute , 2 hour 4 hour post-meal . A full complete blood count ( CBC ) erythrocyte sedimentation rate ( ESR ) blood test also conduct time 0 4 hour post-meal . In addition , questionaire Gastrointestinal symptom administer 4 hour post-meal . The study hypothesis potential marker inflammation increase follow meal , amount increase inflammation attenuate digestive enzyme consume meal compare placebo . In addition , hypothesize level gastric discomfort assess questionaire reduce digestive enzyme compare placebo .</brief_summary>
	<brief_title>Study Investigate Efficacy Digestive Enzymes Inflammation After Meal</brief_title>
	<detailed_description>The primary objective study assess efficacy Digestive Enzyme Blend # 2 , digestive enzyme dietary supplement product , marker indicative inflammation meal . The study design randomize , double-blind , placebo-controlled , cross-over type study . The marker assess blood level TNF-alpha , IL-1beta , IL-6 , hsCRP time 0 , 45 minute , 2 hour 4 hour post-meal . A full blood CBC panel ESR blood test also conduct time 0 4 hour post-meal . In addition , questionaire Gastrointestinal symptom administer 4 hour post-meal . The study hypothesis potential marker inflammation increase follow meal , amount increase inflammation attenuate digestive enzyme consume meal compare placebo . In addition , hypothesize level gastric discomfort assess questionaire reduce digestive enzyme compare placebo .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<criteria>1 . If female , child bear potential . Defined female hysterectomy oophorectomy , bilateral tubal ligation postmenopausal ( natural surgical &gt; 1 year since last menstruation ) . OR Female subject childbearing potential must agree use medically approve method birth control negative urine pregnancy test result . 2 . Healthy determine laboratory result , medical history physical exam 3 . Agrees comply study protocol 4 . Has give voluntary , write , inform consent participate study 1 . Women pregnant , breastfeeding , plan become pregnant course trial . 2 . Gastrointestinal lesions/ulcer , diabetes , condition require use prescribed medication treatment 3 . Immunocompromised individual subject undergo organ transplantation subject diagnose human immunodeficiency virus ( HIV ) 4 . History current diagnosis cancer ( except successfully treat basal cell carcinoma ) diagnose less 5 year prior screen . Subjects cancer full remission 5 year diagnosis acceptable . 5 . History bleed disorder , significant blood loss past 3 month 6 . Use blood thin medication . 7 . Use antiinflammatory medication , include overthecounter pain reliever within past 14 day . 8 . Use prescription medication ( birth control ) , vitamin , mineral natural health product within past 3 day . . 9 . Alcohol use &gt; 2 standard alcoholic drink per day and/or alcohol drug abuse within past year 10 . Allergy sensitivity study supplement ingredient , study meal ingredient allergy sensitivity yeast molds/fungi . 11 . Participation clinical research trial within 30 day prior randomization 12 . Individuals cognitively impair and/or unable give inform consent 13 . Use fish oil supplement within 10 day randomization trial 14 . Any condition Investigator 's opinion may adversely affect subject 's ability complete study measure may pose significant risk subject</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>TNFalpha</keyword>
	<keyword>IL6</keyword>
	<keyword>postprandial</keyword>
	<keyword>digestive</keyword>
	<keyword>inflammation</keyword>
	<keyword>IL1beta</keyword>
	<keyword>CRP</keyword>
	<keyword>CBC</keyword>
	<keyword>ESR</keyword>
</DOC>